NMTC

MKT CAP:$40M

NeuroOne Medical Technologies Corporation

Market Cap

$40M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$4.75+$3.90 (+457.90%)

Apr 24, 2026

Company Details

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroe...

CEO

David A. Rosa

IPO Date

Mar 15, 2018

Website

n1mtc.com

Key Metrics TTM

Revenue

$9M

+51.6% YoY

Net Income

-$7M

EPS (Diluted)

-$0.18

Free Cash Flow

-$6M

Revenue / Share

$0.17

Gross Margin

54.9%

Operating Margin

-87.7%

Net Margin

-78.3%

FCF Margin

-71.8%

P/S

4.6x

P/E

—

Earnings Reports

Q2 2026

May 12, 2026

PENDING

Q1 2026

Feb 17, 2026

$3M-11.7%EPS -$0.03

FY 2025

Dec 16, 2025

$12M+250.4%EPS -$0.09

Q4 2025

Dec 16, 2025

$3M+906.6%EPS -$0.04

Q3 2025

Aug 14, 2025

$2M+105.4%EPS -$0.03

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$36.6K	-$36.2K	-$3M
Q3 22	$32.0K	-$6.4K	-$3M
Q4 22	$68.8K	-$15.1K	-$1M
Q1 23	$114.6K	-$12.3K	-$2M
Q2 23	$466.2K	$31.5K	-$3M
Q3 23	$629.9K	$243.7K	-$4M
Q4 23	$741.8K	$193.7K	-$3M
Q1 24	$977.6K	$266.3K	-$3M
Q2 24	$1M	$390.4K	-$3M
Q3 24	$825.8K	$281.9K	-$3M
Q4 24	$272.3K	$141.1K	-$3M
Q1 25	$3M	$2M	$2M
Q2 25	$1M	$771.1K	-$3M
Q3 25	$2M	$914.8K	-$2M
Q4 25	$3M	$2M	-$1M
Q1 26	$3M	$2M	-$2M

Valuation

Quarter	P/S	P/E
Q2 22	253.6x	—
Q3 22	267.1x	—
Q4 22	235.2x	—
Q1 23	159.8x	—
Q2 23	59.1x	—
Q3 23	31.5x	—
Q4 23	20.6x	—
Q1 24	14.3x	—
Q2 24	10.8x	—
Q3 24	10.3x	—
Q4 24	11.7x	—
Q1 25	7.0x	—
Q2 25	7.0x	—
Q3 25	6.1x	—
Q4 25	4.4x	—
Q1 26	4.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 22	-$3M	-$3M
Q3 22	-$3M	-$3M
Q4 22	$1M	$951.6K
Q1 23	-$3M	-$4M
Q2 23	-$4M	-$4M
Q3 23	-$3M	-$3M
Q4 23	-$3M	-$3M
Q1 24	-$4M	-$4M
Q2 24	-$2M	-$2M
Q3 24	-$2M	-$2M
Q4 24	-$3M	-$3M
Q1 25	$208.0K	$183.6K
Q2 25	-$56.1K	-$59.3K
Q3 25	-$1M	-$2M
Q4 25	-$2M	-$2M
Q1 26	-$3M	-$3M

Capital Expenditures

Quarter	CapEx
Q2 22	$93.3K
Q3 22	$54.2K
Q4 22	$66.2K
Q1 23	$11.5K
Q2 23	$175.7K
Q3 23	$139.3K
Q4 23	$57.6K
Q1 24	$37.1K
Q2 24	$31.4K
Q3 24	$14.8K
Q4 24	$36.9K
Q1 25	$24.4K
Q2 25	$3.2K
Q3 25	$43.5K
Q4 25	$10.6K
Q1 26	$40.8K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 22	+100.6%	+28.3%
Q3 22	-20.1%	-9.2%
Q4 22	+42.3%	-45.4%
Q1 23	+239.5%	-33.2%
Q2 23	+1174.3%	+28.0%
Q3 23	+1865.4%	+48.2%
Q4 23	+978.4%	+165.9%
Q1 24	+753.3%	+130.0%
Q2 24	+195.4%	+7.6%
Q3 24	+31.1%	-12.6%
Q4 24	-63.3%	-20.9%
Q1 25	+234.9%	-64.2%
Q2 25	+0.7%	-4.6%
Q3 25	+105.4%	-1.0%
Q4 25	+906.6%	+33.1%
Q1 26	-11.7%	+194.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 22	$232.7K	636.1%
Q3 22	$255.5K	797.4%
Q4 22	$255.9K	372.0%
Q1 23	$300.2K	262.0%
Q2 23	$237.6K	51.0%
Q3 23	$296.4K	47.1%
Q4 23	$271.2K	36.6%
Q1 24	$308.6K	31.6%
Q2 24	$356.9K	25.9%
Q3 24	$338.6K	41.0%
Q4 24	$340.4K	125.0%
Q1 25	$339.2K	10.4%
Q2 25	$250.2K	18.0%
Q3 25	$316.7K	18.7%
Q4 25	$358.6K	13.1%
Q1 26	$359.3K	12.4%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q2 22	$1M	$2M	$113.2K	—
Q3 22	$1M	$1M	$43.5K	—
Q4 22	$1M	$2M	$52.6K	—
Q1 23	$2M	$2M	$53.0K	—
Q2 23	$2M	$2M	$53.6K	—
Q3 23	$2M	$2M	$49.5K	—
Q4 23	$2M	$2M	$17.3K	—
Q1 24	$1M	$2M	$49.3K	—
Q2 24	$1M	$2M	$15.8K	—
Q3 24	$1M	$2M	$45.0K	—
Q4 24	$1M	$2M	—	—
Q1 25	$1M	$2M	$38.5K	—
Q2 25	$2M	—	—	$2M
Q3 25	$1M	$2M	$45.1K	—
Q4 25	$1M	—	—	$2M
Q1 26	$1M	—	—	$2M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$13M	$0	$13M
Q3 22	$10M	$0	$10M
Q4 22	$8M	$3M	$11M
Q1 23	$5M	$3M	$8M
Q2 23	$4M	$995.4K	$5M
Q3 23	$3M	$0	$3M
Q4 23	$5M	$0	$5M
Q1 24	$3M	$0	$3M
Q2 24	$2M	$0	$2M
Q3 24	$2M	$0	$2M
Q4 24	$1M	$0	$1M
Q1 25	$1M	$0	$1M
Q2 25	$1M	$0	$1M
Q3 25	$8M	$0	$8M
Q4 25	$7M	$0	$7M
Q1 26	$4M	$0	$4M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	16M	+5.1%	+44.1%
Q3 22	16M	+0.0%	+35.4%
Q4 22	16M	+0.1%	+35.0%
Q1 23	16M	+0.1%	+5.3%
Q2 23	16M	+1.1%	+1.4%
Q3 23	18M	+7.1%	+8.6%
Q4 23	24M	+33.8%	+45.0%
Q1 24	24M	+2.0%	+47.8%
Q2 24	26M	+8.0%	+57.8%
Q3 24	27M	+5.6%	+55.6%
Q4 24	27M	-2.2%	+13.8%
Q1 25	31M	+15.4%	+28.7%
Q2 25	31M	+0.7%	+20.1%
Q3 25	49M	+56.2%	+77.7%
Q4 25	40M	-17.4%	+50.0%
Q1 26	50M	+25.3%	+63.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 22	$3.3K	11
Q3 22	$2.9K	11
Q4 22	$4.6K	15
Q1 23	$7.6K	15
Q2 23	$31.1K	15
Q3 23	$42.0K	15
Q4 23	$46.4K	16
Q1 24	$61.1K	16
Q2 24	$86.1K	16
Q3 24	$51.6K	16
Q4 24	$16.0K	17
Q1 25	$192.6K	17
Q2 25	$81.6K	17
Q3 25	$99.8K	17
Q4 25	$18	150K
Q1 26	$19	150K

Revenue / Employee